Polypeptide hormone phosphatonin
    41.
    发明授权
    Polypeptide hormone phosphatonin 有权
    多肽激素磷黄素

    公开(公告)号:US06818745B1

    公开(公告)日:2004-11-16

    申请号:US09700696

    申请日:2001-06-12

    IPC分类号: C07K14435

    摘要: The present invention relates to a novel human protein called phosphatonin, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.

    摘要翻译: 本发明涉及一种称为磷酸肌钙蛋白的新型人蛋白质,以及编码该蛋白质的分离的多核苷酸。 还提供了用于产生该人蛋白质的载体,宿主细胞,抗体和重组方法。 本发明还涉及用于诊断和治疗与该新型人蛋白相关的疾病的诊断和治疗方法。

    Human neuronal attachment factor-1
    43.
    发明授权
    Human neuronal attachment factor-1 失效
    人类神经元附着因子-1

    公开(公告)号:US06759512B1

    公开(公告)日:2004-07-06

    申请号:US09170042

    申请日:1998-10-13

    IPC分类号: C07K14435

    摘要: A human F-spondin-like protein and DNA (RNA) encoding such protein and a procedure for producing such protein by recombinant techniques is disclosed. Also disclosed are methods for utilizing such polypeptide for treating spinal cord injuries and damage to peripheral nerves by promoting neural-cell adhesion and neurite extension, inhibiting tumor metastases and tumor angiogenesis, and stimulating wound repair. Antagonists are also disclosed which may be utilized to prevent malaria. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention for detecting diseases, for example, cancer, are also disclosed.

    摘要翻译: 公开了一种编码这种蛋白质的人类F-脊椎样蛋白样蛋白和DNA(RNA)以及通过重组技术产生这种蛋白质的方法。 还公开了通过促进神经细胞粘附和神经突延伸,抑制肿瘤转移和肿瘤血管发生以及刺激伤口修复来利用这种多肽来治疗脊髓损伤和损伤周围神经的方法。 还公开了可用于预防疟疾的拮抗剂。 还公开了用于鉴定编码本发明多肽的核酸序列中的突变并用于检测用于检测疾病例如癌症的本发明多肽的改变水平的诊断测定法。

    Human elastase IV
    47.
    发明授权
    Human elastase IV 失效
    人弹性蛋白酶IV

    公开(公告)号:US06602984B1

    公开(公告)日:2003-08-05

    申请号:US09613822

    申请日:2000-07-11

    IPC分类号: C07K14435

    CPC分类号: C12N9/6424 A61K38/00

    摘要: Human elastase IV polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptide by recombinant techniques and utilizing such polypeptide for therapeutic purposes, for example, restoration of elasticity of arterial walls, improvement of serum lipid abnormality and improvement of serum lipoprotein metabolism are disclosed. Also disclosed are antagonist/inhibitors against such polypeptides and their use in treating inflammation, arthritis, e.g. rheumatoid arthritis and osteoarthritis, septic shock, pancreatitis and limiting tissue damage in ulceration. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.

    摘要翻译: 人弹性蛋白酶IV多肽和编码这种多肽的DNA(RNA)以及通过重组技术产生这种多肽的方法,并且用于治疗目的,例如恢复动脉壁的弹性,改善血清脂质异常和改善血清脂蛋白 公开了代谢。 还公开了针对这种多肽的拮抗剂/抑制剂及其在治疗炎症,关节炎等中的用途。 类风湿关节炎和骨关节炎,脓毒性休克,胰腺炎和限制溃疡组织损伤。 还公开了用于鉴定编码本发明多肽的核酸序列中突变和用于检测本发明多肽的改变水平的诊断测定。

    Vertebrate apoptosis gene: compositions and methods
    49.
    发明授权
    Vertebrate apoptosis gene: compositions and methods 失效
    脊椎动物凋亡基因:组成和方法

    公开(公告)号:US06395510B1

    公开(公告)日:2002-05-28

    申请号:US09271014

    申请日:1999-03-17

    IPC分类号: C07K14435

    CPC分类号: C07K14/4747 C07K14/465

    摘要: The invention relates generally to compositions of and methods for obtaining and using a polypeptide other than BCL-2 that affects programmed vertebrate cell death. The invention relates as well to polynucleotides encoding those polypeptides, recombinant vectors carrying those sequences, the recombinant host cells including either the sequences or vectors, and recombinant polypeptides. The invention further provides methods for using the isolated, recombinant polypeptides in assays designed to select and improve substances capable of altering programmed cell death for use in diagnostic, drug design and therapeutic applications.

    摘要翻译: 本发明一般涉及获得和使用影响程序性脊椎动物细胞死亡的BCL-2以外的多肽的组合物和方法。 本发明还涉及编码那些多肽的多核苷酸,携带那些序列的重组载体,包含序列或载体的重组宿主细胞和重组多肽。 本发明还提供了在分析设计用于选择和改善能够改变程序性细胞死亡的物质用于诊断,药物设计和治疗应用的测定中使用分离的重组多肽的方法。

    Human cardiac/brain tolloid-like protein
    50.
    发明授权
    Human cardiac/brain tolloid-like protein 失效
    人类心脏/脑体外样蛋白

    公开(公告)号:US06365715B1

    公开(公告)日:2002-04-02

    申请号:US09432473

    申请日:1999-11-01

    IPC分类号: C07K14435

    摘要: HC/BTLP polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing hC/BTLP polypeptides and polynucleotides in the design of protocols for the treatment of restenosis, atherosclerosis, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), benign prostatic hypertrophy (BPH), nephritis, fibrosis, glomerulonephritis, gliosis, cirrhosis and anomalies of wound healing, such as keloids among others, and diagnostic assays for such conditions.

    摘要翻译: 公开了通过重组技术制备此类多肽的HC / BTLP多肽和多核苷酸和方法。 还公开了在设计用于治疗再狭窄,动脉粥样硬化,充血性心力衰竭(CHF),慢性阻塞性肺病(COPD),良性前列腺肥大(BPH),肾炎,纤维化)的方案中使用hC / BTLP多肽和多核苷酸的方法 ,肾小球性肾炎,神经胶质增生,肝硬化和伤口愈合的异常,例如瘢痕疙瘩等,以及这些病症的诊断测定。